Investors Sell CVS Health (CVS) on Strength (CVS)

Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading on Monday. $69.33 million flowed into the stock on the tick-up and $131.55 million flowed out of the stock on the tick-down, for a money net flow of $62.22 million out of the stock. Of all stocks tracked, CVS Health had the 28th highest net out-flow for the day. CVS Health traded up $1.41 for the day and closed at $71.90

Several analysts have recently issued reports on CVS shares. Leerink Swann set a $85.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Monday, December 4th. Needham & Company LLC upped their price target on CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research note on Monday, December 4th. Deutsche Bank started coverage on CVS Health in a research note on Monday, December 4th. They set a “buy” rating and a $90.00 price target for the company. Cowen set a $86.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Sunday, October 29th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $87.82.

The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The firm has a market cap of $72,830.00, a PE ratio of 11.11, a price-to-earnings-growth ratio of 1.22 and a beta of 0.92.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, beating the consensus estimate of $1.88 by $0.04. The firm had revenue of $48.39 billion during the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.71 EPS. research analysts predict that CVS Health Corp will post 6.38 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.78%. CVS Health’s dividend payout ratio (DPR) is 30.91%.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the transaction, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.61% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Sawtooth Solutions LLC raised its holdings in shares of CVS Health by 12.6% in the 4th quarter. Sawtooth Solutions LLC now owns 8,110 shares of the pharmacy operator’s stock worth $588,000 after buying an additional 908 shares in the last quarter. We Are One Seven LLC acquired a new position in shares of CVS Health in the 4th quarter worth approximately $805,000. Salem Investment Counselors Inc. raised its holdings in shares of CVS Health by 20.2% in the 4th quarter. Salem Investment Counselors Inc. now owns 81,660 shares of the pharmacy operator’s stock worth $5,920,000 after buying an additional 13,726 shares in the last quarter. Compagnie Lombard Odier SCmA raised its holdings in shares of CVS Health by 14.0% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 9,936 shares of the pharmacy operator’s stock worth $721,000 after buying an additional 1,221 shares in the last quarter. Finally, First Commonwealth Financial Corp PA raised its holdings in shares of CVS Health by 12.0% in the 4th quarter. First Commonwealth Financial Corp PA now owns 12,569 shares of the pharmacy operator’s stock worth $911,000 after buying an additional 1,343 shares in the last quarter. 83.23% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Investors Sell CVS Health (CVS) on Strength (CVS)” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/19/investors-sell-cvs-health-cvs-on-strength-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply